Estimation of peginesatide utilization requires patient-level data
Post hoc analysis of two Phase 3 pivotal trials (EMERALD 1,2) of peginesatide vs epoetin for anemia due to chronic kidney disease in hemodialysis patients on stable epoetin showed that for increasing doses of baseline epoetin, relatively less peginesatide was needed to achieve similar Hb levels (Fis...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |